In this week’s Pharma Pulse, Lilly brings Zepbound and Foundayo to Hims & Hers, Swisslog Healthcare expands its Tenutō cold storage line, and FDA adds a NAION warning across the GLP-1 class.
|Articles|September 3, 2018
- Pharmaceutical Commerce - September 2018
- Volume 13
- Issue 3
Cold Chain Suppliers Spotlight Directory
Advertisement
Articles in this issue
about 8 years ago
Gimme my dataabout 8 years ago
A Conversation with Rafik Bisharaabout 8 years ago
The 2018 Pharma Cold Chain: more data leads to less riskabout 8 years ago
Biopharma cold-chain market forecastAdvertisement
Related to this article
ELPRO CEO Frederik Dresen explains how cold chain monitoring moved from compliance to risk management, and what biologics and advanced therapies demand.
Foreign-trade zones allow pharma companies to hold imported inventory closer to U.S. demand while deferring duties and keeping market allocation open.
GEODIS' David Frouin explains why securing the lane outranks sustainability and why full corridor models are the cold chain trend to watch.
At LogiPharma USA 2026, Cold Chain Technologies' Vijay Paliwal discusses reusable shippers, PCM innovation and AI's role in cold chain risk.
CSafe's Aaron Mantia explains how lane, temperature range, duration and product cost shape thermal protection choices for bulk air cargo.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how automation cuts human touches, enforces quarantine and consolidates cold storage.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
CVS Health’s Breakup: A Turning Point for Pharma Supply Chains or a Redistribution of Market Power?
2
When Drug Pricing Collides With Politics
3
Idle US Capacity Could Anchor Generic Drug Reshoring, APIIC Says
4
The End of the Traditional Launch: How JCA, HTA Evolution and Pricing Pressures Are Driving Continuous Evidence Generation
5